shRNA set against Mouse ARL8B (NM_026011.3)

Name: shRNA set against Mouse ARL8B (NM_026011.3)
SKU: SHH240350
Availability: InStock

For research use only. Not intended for any clinical use.

Cat. No. : SHH240350

Inquire for Price

Product Information

Gene Information

Cat. No.	SHH240350
Description	The SureSilencing trade; shRNA Plasmids are designed to specifically knock down the expression of individual genes by RNA interference under either transient (with GFP) or stable transfection (for hygromycin, neomycin or puromycin-resistance) conditions after performance of the appropriate enrichment or selection procedures, respectively. Each vector contains the shRNA under control of the U1 promoter and either the GFP gene, for the enrichment of transiently transfected cells, or the neomycin or puromycin resistance genes, for the selection of stably transfected cells.
Gene Abbr	ARL8B
Gene Name	Arl8b ADP-ribosylation factor-like 8B [ Mus musculus ]
Species	Mouse
Report Gene	GFP
Storage	The SureSilencing shRNA Plasmids are shipped on dry ice or cold packs. Store all tubes at -20°C.

Gene Name	Arl8b ADP-ribosylation factor-like 8B [ Mus musculus ]
Gene Symbol	Arl8b
Synonyms	gie1; Arl10c; 2610313E07Rik; 3100002J04Rik
Gene Description	ADP-ribosylation factor-like 8B
GeneID	67166
Uni ProtID	Q9CQW2
mRNA Refseq	NM_026011.3
Protein Refseq	NP_080287.1
Chromosome Location	6 E2; 6
Function	GDP binding; GTP binding; alpha-tubulin binding; beta-tubulin binding; nucleotide binding;

Quick Inquiry

Q & A

Customer Reviews

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Question *

Name

Country *

Email *

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Product Name *

Catalog Name *

Rating

Needs improvement

Satisfaction

General satisfaction

Very satisfaction

Product Review Title *

Summary *